We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · April 27, 2020

Dose of Four-Factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors

Journal of Intensive Care Medicine


Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Intensive Care Medicine
Comparison of Low- Versus High-Dose Four-Factor Prothrombin Complex Concentrate (4F-PCC) for Factor Xa Inhibitor-Associated Bleeding: A Retrospective Study
J Intensive Care Med 2020 Apr 03;[EPub Ahead of Print], HA Wilsey, AM Bailey, A Schadler, GA Davis, M Nestor, K Pandya

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading